EFFICACY OF TOCILIZUMAB IN 31 PATIENTS WITH GIANT CELL ARTERITIS

被引:0
|
作者
Dominguez-Casas, L. C. [1 ]
Loricera, J. [1 ]
Hernandez, J. L. [2 ]
Castaneda, S. [3 ]
Mera, A. [4 ]
Perez-Pampin, E. [4 ]
Peiro, E. [1 ]
Humbria, A. [3 ]
Calvo-Alen, J. [5 ]
Aurrecoechea, E. [5 ]
Narvaez, J. [6 ]
Sanchez-Andrade, A. [7 ]
Vela, P. [8 ]
Diez, E. [9 ]
Mariano, C. [9 ]
Lluch, P. [10 ]
Moll, C. [10 ]
Hernandez, I. [11 ]
Calvo-Rio, V. [1 ]
Ivorra, J. [12 ]
Corrales, A. [1 ]
Ortiz-Sanjuan, F. [12 ]
Gonzalez-Vela, C. [1 ]
Gonzalez-Gay, M. A. [1 ]
Blanco, R. [1 ]
机构
[1] Hosp Univ Marques de Valdecilla, IDIVAL, Rheumatol, Santander, Spain
[2] Hosp Univ Marques de Valdecilla, IDIVAL, Internal Med, Santander, Spain
[3] Hosp Univ Princesa, Rheumatol, IIS IP, Madrid, Spain
[4] Complejo Hosp Univ Santiago, Rheumatol, Santiago De Compostela, Spain
[5] Hosp Sierrallana, Rheumatol, Torrelavega, Spain
[6] Hosp Bellvitge Princeps Espanya, Rheumatol, Barcelona, Spain
[7] Hosp Univ Lucus Augusti, Rheumatol, Lugo, Spain
[8] Hosp Gen Univ Alicante, Rheumatol, Alicante, Spain
[9] Complejo Asistencial Univ Leon, Rheumatol, Leon, Spain
[10] Hosp Mateu Orfila, Rheumatol, Menorca, Spain
[11] Complexo Hosp Univ Vigo, Rheumatol, Vigo, Spain
[12] Hosp Univ & Politecn la Fe, Rheumatol, Valencia, Spain
关键词
D O I
10.1136/annrheumdis-2017-eular.3262
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
FRI0336
引用
收藏
页码:614 / 614
页数:1
相关论文
共 50 条
  • [21] Vision loss in patients with giant cell arteritis treated with tocilizumab
    Amsler, Jennifer
    Kysela, Iveta
    Tappeiner, Christoph
    Seitz, Luca
    Christ, Lisa
    Scholz, Godehard
    Stalder, Odile
    Kollert, Florian
    Reichenbach, Stephan
    Villiger, Peter M.
    ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [22] Assessment of the efficacy and safety of tocilizumab in patients over 80 years old with giant cell arteritis
    Hubert de Boysson
    Maelle Le Besnerais
    Félix Blaison
    Aurélie Daumas
    Pierre-André Jarrot
    François Perrin
    Nathalie Tieulié
    Alexandre Maria
    Pierre Duffau
    Bruno Gombert
    Maxime Samson
    Olivier Espitia
    Marc Lambert
    Arsène Mékinian
    Achille Aouba
    Arthritis Research & Therapy, 23
  • [23] Assessment of the efficacy and safety of tocilizumab in patients over 80 years old with giant cell arteritis
    de Boysson, Hubert
    Le Besnerais, Maelle
    Blaison, Felix
    Daumas, Aurelie
    Jarrot, Pierre-Andre
    Perrin, Francois
    Tieulie, Nathalie
    Maria, Alexandre
    Duffau, Pierre
    Gombert, Bruno
    Samson, Maxime
    Espitia, Olivier
    Lambert, Marc
    Mekinian, Arsene
    Aouba, Achille
    ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [24] VISUAL LOSS IN PATIENTS WITH GIANT CELL ARTERITIS TREATED WITH TOCILIZUMAB
    Amsler, J.
    Kysela, I.
    Christ, L.
    Tappeiner, C.
    Seitz, L.
    Scholz, G.
    Kollert, F.
    Reichenbach, S.
    Villiger, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 95 - 95
  • [25] Tocilizumab in patients with giant cell arteritis: for whom and for how long?
    Quinn, Kaitlin A.
    LANCET RHEUMATOLOGY, 2021, 3 (05): : E314 - E315
  • [26] Vision loss in patients with giant cell arteritis treated with tocilizumab
    Jennifer Amsler
    Iveta Kysela
    Christoph Tappeiner
    Luca Seitz
    Lisa Christ
    Godehard Scholz
    Odile Stalder
    Florian Kollert
    Stephan Reichenbach
    Peter M. Villiger
    Arthritis Research & Therapy, 23
  • [27] EFFICACY OF TOCILIZUMAB USE IN GIANT CELL ARTERITIS (GCA) AND TAKAYASU ARTERITIS (TA) PATIENTS ALLOWING GLUCOCORTICOID DOSE REDUCTION
    Singh, Malinder
    Scott, Naomi
    Hauser, Barbara
    RHEUMATOLOGY, 2019, 58 : 84 - 84
  • [28] Lights and shadows on the efficacy of tocilizumab monotherapy in large vessel giant cell arteritis
    Gonzalez-Gay, Miguel Angel
    Castaneda, Santos
    Heras-Recuero, Elena
    Largo, Raquel
    RHEUMATOLOGY, 2024, 63 (01) : 6 - 7
  • [29] EFFICACY AND SAFETY OF TOCILIZUMAB IN GIANT CELL ARTERITIS INDEPENDENTLY OF THE INICIAL PREDNISONE DOSE
    Calderon-Goercke, Monica
    Loricera, J.
    Prieto-Pena, D.
    Aldasoro, Vicente
    Castaneda, Santos
    Villa-Blanco, Ignacio
    Humbria, Alicia
    Moriano, Clara
    Romero-Yuste, Susana
    Narvaez, J.
    Gomez-Arango, Catalina
    Perez-Pampin, Eva
    Melero, Rafael
    Becerra-Fernandez, Elena
    Revenga, Marcelino
    Alvarez-Rivas, Noelia
    Galisteo, Carles
    Sivera, Francisca
    Olive, Alejandro
    Alvarez del Buergo, Maria
    Marena Rojas, Luisa
    Fernandez-Lopez, Carlos
    Navarro, Francisco
    Raya, Enrique
    Galindez, Eva
    Arca, Beatriz
    Solans-Laque, Roser
    Conesa, Arantxa
    Hidalgo, Cristina
    Vazquez, Carlos
    Andres Roman-Ivorra, Jose
    Lluch, Pau
    Manrique Arija, Sara
    Vela-Casasempere, Paloma
    de Miguel, Eugenio
    Torres-Martin, Carmen
    Carlos Nieto, Juan
    Ordas-Calvo, Carmen
    Salgado-Perez, Eva
    Luna-Gomez, Cristina
    Toyos Saenz de Miera, J. Francisco
    Fernandez-Llanio, Nagore
    Garcia, Antonio
    Larena, Carmen
    Palmou-Fontana, Natalia
    Calvo-Rio, Vanesa
    Gonzalez-Vela, Carmen
    Corrales, Alfonso
    Varela-Garcia, Maria
    Aurrecoechea, Elena
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1185 - 1185
  • [30] Tocilizumab in giant cell arteritis: an update for the clinician
    Ford, Julia A.
    Gewurz, Danya
    Gewurz-Singer, Ora
    CURRENT OPINION IN RHEUMATOLOGY, 2023, 35 (03) : 135 - 140